IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Inovio Pharmaceuticals Inc

CUSIP: 45773H102 | 104 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q4 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Byrne Asset Management LLC4
0.0% of portfolio›$5
StyleTurnoverLocationFiled
Byrne Asset Management LLC
4$50.0%CoreLowKingston, NJ2026-10-06